(Q41615861)

5 October 2017

title

Reduced intrapatient variability of cyclosporine pharmacokinetics in renal transplant recipients switched from oral Sandimmune to Neoral (English)

1 reference

5 October 2017

1 reference

Mendez R

1

1 reference

5 October 2017

Abboud H

2

1 reference

5 October 2017

Burdick J

3

1 reference

5 October 2017

Copley B

4

1 reference

5 October 2017

Freeman R

5

1 reference

5 October 2017

Batiuk TD

6

1 reference

5 October 2017

Cooney GF

7

1 reference

5 October 2017

Barbeito R

8

1 reference

5 October 2017

publication date

1 January 1999

1 reference

5 October 2017

published in

Clinical Therapeutics

1 reference

5 October 2017

volume

21

1 reference

5 October 2017

issue

1

1 reference

5 October 2017

page(s)

160-171

1 reference

The relationship between cyclosporine pharmacokinetic parameters and subsequent acute rejection in renal transplant recipients

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988276-4

7 January 2021

Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988276-4

7 January 2021

On the intraindividual variability and chronobiology of cyclosporine pharmacokinetics in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988276-4

7 January 2021

Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988276-4

7 January 2021

Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988276-4

7 January 2021

Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988276-4

7 January 2021

Neoral versus Sandimmun in kidney-pancreas transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988276-4

7 January 2021

Pharmacokinetics of an oral solution of the microemulsion formulation of cyclosporine in maintenance pediatric liver transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988276-4

7 January 2021

Noncompartmental Determination of the Steady‐State Volume of Distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988276-4

7 January 2021

Clinical development of a cyclosporine microemulsion in transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988276-4

7 January 2021

A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988276-4

7 January 2021

Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study period

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988276-4

7 January 2021

Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients: a report of the Canadian Neoral Renal Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988276-4

7 January 2021

10.1016/S0149-2918(00)88276-4

Identifiers

DOI

1 reference

5 October 2017

1 reference